Literature DB >> 14675185

Pathogenicity and epitope characteristics of anti-desmoglein-1 from pemphigus foliaceus patients expressing only IgG1 autoantibodies.

Mary K Hacker-Foegen1, Marleen Janson, Masayuki Amagai, Janet A Fairley, Mong-Shang Lin.   

Abstract

Pemphigus foliaceus (PF) is an antibody-mediated autoimmune disorder with IgG1 and IgG4 as the predominant subclasses of autoantibodies against a desmosomal glycoprotein, desmoglein-1 (Dsg1). Previously, we found that the IgG4 anti-Dsg1 autoantibodies only recognize a conformational epitope(s), whereas the IgG1 autoantibodies recognize both conformational and linear epitopes but do not display pathogenicity in the passive transfer animal model. The purpose of this study was to analyze the epitopes recognized by autoanti-bodies from a subset of PF patients who only express anti-Dsg1 of the IgG1 isotype throughout the course of their diseases and to further characterize the pathogenicity of their IgG1 anti-Dsg1. We found that IgG1 auto-antibodies in this subset of PF patients, similar to IgG4 autoantibodies from other PF patients, are able to bind both human and mouse skin and induce the experimental PF in mice. Moreover, a detailed epitope mapping reveals that the conformational epitopes recognized by IgG1 autoantibodies from these PF patients are restricted to the first 161 amino acids of Dsg1, whereas the linear epitopes are spread throughout the entire ectodomain. In conclusion, our study reveals that the isotype of IgG does not necessarily determine the epitopes and pathogenicity of pemphigus autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675185     DOI: 10.1111/j.1523-1747.2003.12608.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30

Review 3.  IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.

Authors:  Maartje G Huijbers; Jaap J Plomp; Silvère M van der Maarel; Jan J Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

4.  Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.

Authors:  Alberta Lucchese; Abraham Mittelman; Luciana Tessitore; Rosario Serpico; Animesh A Sinha; Darja Kanduc
Journal:  J Transl Med       Date:  2006-08-22       Impact factor: 5.531

Review 5.  The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.

Authors:  Cassian Sitaru; Sidonia Mihai; Detlef Zillikens
Journal:  Arch Dermatol Res       Date:  2007-02-03       Impact factor: 3.017

Review 6.  The desmosome and pemphigus.

Authors:  Jens Waschke
Journal:  Histochem Cell Biol       Date:  2008-04-03       Impact factor: 4.304

7.  Autoantibodies in senear-usher syndrome: cross-reactivity or multiple autoimmunity?

Authors:  María Elena Pérez-Pérez; Esperanza Avalos-Díaz; Rafael Herrera-Esparza
Journal:  Autoimmune Dis       Date:  2012-12-20

8.  IgG4 autoantibodies induce dermal-epidermal separation.

Authors:  Sidonia Mihai; Mircea T Chiriac; Josep E Herrero-González; Margaret Goodall; Roy Jefferis; Caroline O S Savage; Detlef Zillikens; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.